There’s hope emanating in the face of impending disaster as the world succumbs slowly to Coronavirus.
The virus-triggered ailment has killed over twenty-six thousand people and infected over 571,000 globally with the figures soaring -rather alarmingly -by each day.
However, there appears some glimmer of hope sprouting in a revelation that could go on to heal the frail globe of this menace.
This newfound optimism is being championed by an African-born -to be precise a Senegalese by birth -in a soon-to-be-confirmed experimentation that will yet again remind the world of the ingenuity of the sons of our continent often poached away by developed nations.
His name is Didier Raoult. He was born 68 years ago and schooled in France at the Marseille university where he bagged a PhD in scientific studies.
A respected researcher and virologist, Raoult launched a study at a time the world was searching for answers to curb a pandemic spanning back December last year in China.
His first trial in attempt at discovery of a cure involved just thirty-six coronavirus patients using anti-malaria drugs.
Using a combination of hydroxychloroquine (brand name Plaquenil) and Azithromycin, he was able to ensure cure of all thirty-six patients in a space of six days. However, his method raised some eyebrows from US health agencies who have reservations over the small figure of patients deployed for the trial.
Aimed at proving authenticity of his claim, Didier this time involved eighty people who’re sufferers of the Covid-19. The objective of the study was to secure a definite solution to the pandemic.
A similar improvement was registered from amongst patients used for the audition with the exception of an 86-year-old who died while another 76-year-old remains in intensive care.
Defending the trial, the professor and his team suggest the jump in the list of improving patients was down to the administering of the aforesaid drugs at the early stage of the covid-19, prompting questions over its effectiveness at a latter stage of infection.
The thesis published by a revered scientific journal, also comprised tabular breakdown of the various methods deployed at varying stages of the ailment in the quest for cure.
In conclusion, we confirm the efficacy of hydroxychloroquine associated with azithromycin in the treatment of COVID-19 and its potential effectiveness in the early impairment of contagiousness. Given the urgent therapeutic need to manage this disease with effective and safe drugs and given the negligible cost of both hydroxychloroquine and azithromycin, we believe that other teams should urgently evaluate this therapeutic strategy both to avoid the spread of the disease and to treat patients before severe irreversible respiratory complications take hold,” the professor and team concluded.
Interesting to note during Gambia News’ compilation of articles on Didier, is numerous or rather deliberate attempts by respected tabloids to conceal the researcher’s Senegalese identity with most addressing him as a “French scientist”.